544 related articles for article (PubMed ID: 27984651)
1. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
[TBL] [Abstract][Full Text] [Related]
2. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
[TBL] [Abstract][Full Text] [Related]
3. Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons.
Wu TC; Sanford NN; Anand S; Chu FI; Wo JY; Raldow AC
Clin Colorectal Cancer; 2022 Dec; 21(4):309-314. PubMed ID: 36216758
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.
Senyurek S; Saglam S; Saglam EK; Yanar H; Gok K; Tastekin D; Akbas CK; Sakin ND; Kartal GD; Balik E; Keskin M; Sanli Y; Gulluoglu M; Akgun Z
Oncol Res; 2023; 31(5):689-696. PubMed ID: 37547762
[TBL] [Abstract][Full Text] [Related]
5. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
[TBL] [Abstract][Full Text] [Related]
6. Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO.
Spatola C; Privitera G; Milazzotto R; Tocco A; Acquaviva G; Marletta F; Marino L; Di Grazia A; Salvo R; Cartia G; Platania A; Molino L; Santacaterina A; Mattace Raso M; Frosina P; Ianni R; Bono M; Liardo L; Bonanno S; La Paglia L; Federico M; Fazio I; Mortellaro G; Ferrera G; Tripoli A; Evangelista G; Daidone A; Biti G; Badalamenti M; Ognibene L; Cacciola A; Parisi S; Pergolizzi S
Radiol Med; 2019 Jul; 124(7):671-681. PubMed ID: 30806918
[TBL] [Abstract][Full Text] [Related]
7. Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer.
Wang J; Long Y; Liu K; Pei Q; Zhu H
BMC Gastroenterol; 2021 Jul; 21(1):277. PubMed ID: 34233606
[TBL] [Abstract][Full Text] [Related]
8. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
10. The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B; Mackay J; Ngan SY
Eur J Cancer; 2016 Mar; 55():15-26. PubMed ID: 26771873
[TBL] [Abstract][Full Text] [Related]
11. Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2018 Nov; 19(6):e815-e821. PubMed ID: 29857969
[TBL] [Abstract][Full Text] [Related]
12. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium.
Bauer PS; Gamboa AC; Otegbeye EE; Chapman WC; Rivard S; Regenbogen S; Mohammed M; Holder-Murray J; Wiseman JT; Ejaz A; Edwards-Hollingsworth K; Hawkins AT; Hunt SR; Balch G; Silviera ML
J Surg Oncol; 2024 Feb; 129(2):254-263. PubMed ID: 37792637
[TBL] [Abstract][Full Text] [Related]
13. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.
Latkauskas T; Pauzas H; Kairevice L; Petrauskas A; Saladzinskas Z; Janciauskiene R; Gudaityte J; Lizdenis P; Svagzdys S; Tamelis A; Pavalkis D
BMC Cancer; 2016 Dec; 16(1):927. PubMed ID: 27903247
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?
Rödel C; Trojan J; Bechstein WO; Woeste G
Dig Dis; 2012; 30 Suppl 2():102-8. PubMed ID: 23207941
[TBL] [Abstract][Full Text] [Related]
16. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.
Crawford A; Firtell J; Caycedo-Marulanda A
J Gastrointest Cancer; 2019 Jun; 50(2):260-268. PubMed ID: 29388060
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns.
Elliott DA; Rana SR; Nabavizadeh N; Chen Y; Kusano A; Holland JM; Mitin T
Anticancer Res; 2018 Nov; 38(11):6375-6379. PubMed ID: 30396960
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
[TBL] [Abstract][Full Text] [Related]
19. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
20. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Guckenberger M; Saur G; Wehner D; Sweeney RA; Thalheimer A; Germer CT; Flentje M
Strahlenther Onkol; 2012 Jul; 188(7):551-7. PubMed ID: 22638934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
